daily oral glp-1 receptor agonist orforglipron for adults with obesity FDA Approves Orforglipron, an Agonist, Treatment Lilly orforglipron oral GLP-1 phase

Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review

doi: 10.4168/aair.2021.13.2.284 [PubMed] 33500632 Caruso C, Valluzzi RL, Colantuono S, Gaeta F, Romano A

Egr-1 functions as a master switch activated by ischemia to trigger expression of pivotal regulators of inflammation, coagulation and vascular hyperpermeability [38]

Oxidative Stress & Neuroprotection: Explored for its ability to reduce lipid peroxidation and act as a potential antioxidant within neuronal environments

Its most critical roles include oxygen storage (such as myoglobin), transport (such as hemoglobin), and cellular utilization (such as oxidases and the electron transport chain)

& Shaaban, M